Abstract：Objective To study the clinical and neuroelectrophysiological features of botulism in children. Methods A retrospective analysis was conducted on the clinical data of eight children who were diagnosed with botulism in the Department of Neurology, Hunan Children's Hospital, from August 2015 to October 2022. Results All eight children were found to have symmetrical cranial nerve palsy and flaccid paralysis of the extremities, with a descending pattern. Seven children presented with respiratory muscle paralysis. Electrophysiological examinations revealed decreased compound muscle action potential (CMAP) amplitudes in 5 children, increased CMAP amplitudes exceeding 40.0% in 6 children during high-frequency repetitive nerve stimulation, and short duration, low amplitude, and polyphasic motor unit action potentials in 4 children. Conclusions The main clinical features of botulism in children include symmetric, descending flaccid paralysis starting from cranial nerves, with the possibility of respiratory muscle paralysis. Electrophysiological abnormalities associated with it include decreased CMAP amplitudes, increased CMAP amplitudes during high-frequency repetitive nerve stimulation, and short duration, low amplitude, and polyphasic motor unit action potentials.
PENG Qin-Ling,WANG Ping,HU Nan. Clinical and neuroelectrophysiological features of botulism in children: an analysis of eight sporadic cases[J]. CJCP, 2023, 25(9): 936-940.
Dembek ZF, Smith LA, Rusnak JM. Botulism: cause, effects, diagnosis, clinical and laboratory identification, and treatment modalities[J]. Disaster Med Public Health Prep, 2007, 1(2): 122-134. PMID: 18388640. DOI: 10.1097/DMP.0b013e318158c5fd.
5 World Health Organization. Botulism[EB/OL]. (2018-01-10)[2023-01-24]. https://www.who.int/en/news-room/fact-sheets/detail/botulism.
Rao AK, Lin NH, Griese SE, et al. Clinical criteria to trigger suspicion for botulism: an evidence-based tool to facilitate timely recognition of suspected cases during sporadic events and outbreaks[J]. Clin Infect Dis, 2017, 66(suppl_1): S38-S42. PMID: 29293926. DOI: 10.1093/cid/cix814.
Rao AK, Lin NH, Jackson KA, et al. Clinical characteristics and ancillary test results among patients with botulism: United States, 2002-2015[J]. Clin Infect Dis, 2017, 66(suppl_1): S4-S10. PMID: 29293936. DOI: 10.1093/cid/cix935.
Boccagni C, Prestandrea C, D'Agostino T, et al. Neurophysiological patterns of acute and post-acute foodborne botulism[J]. Muscle Nerve, 2021, 64(4): 435-444. PMID: 34255868. DOI: 10.1002/mus.27370.
Khan MR, Maheshwari PK, Ibrahim SH, et al. Botulism in children: a diagnostic dilemma in developing countries[J]. J Coll Physicians Surg Pak, 2013, 23(6): 443-444. PMID: 23763811.
Schussler E, Sobel J, Hsu J, et al. Workgroup report by the joint task force involving American Academy of Allergy, Asthma & Immunology (AAAAI); Food Allergy, Anaphylaxis, Dermatology and Drug Allergy (FADDA) (Adverse Reactions to Foods Committee and Adverse reactions to Drugs, Biologicals, and Latex Committee); and the Centers for Disease Control and Prevention Botulism Clinical Treatment Guidelines Workgroup—allergic reactions to botulinum antitoxin: a systematic review[J]. Clin Infect Dis, 2017, 66(suppl_1): S65-S72. PMID: 29293931. PMCID: PMC5850017. DOI: 10.1093/cid/cix827.
Yu PA, Lin NH, Mahon BE, et al. Safety and improved clinical outcomes in patients treated with new equine-derived heptavalent botulinum antitoxin[J]. Clin Infect Dis, 2017, 66(suppl_1): S57-S64. PMID: 29293928. PMCID: PMC5866099. DOI: 10.1093/cid/cix816.
O'Horo JC, Harper EP, El Rafei A, et al. Efficacy of antitoxin therapy in treating patients with foodborne botulism: a systematic review and meta-analysis of cases, 1923-2016[J]. Clin Infect Dis, 2017, 66(suppl_1): S43-S56. PMID: 29293927. PMCID: PMC5850555. DOI: 10.1093/cid/cix815.
